Gufic Biosciences CEO, chairman, board of directors and AGM
NSE: GUFICBIOBSE: 509079Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹418.80.
30 Oct: open ₹416.90, high ₹423.00, low ₹407.70
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹4,147 Cr959th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 56.46
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 6.24
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.02%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 11.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.58
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 70,25448.5% delivered
Gufic Biosciences' chairperson and managing director is JAYESH PANNALAL CHOKSI and its chief executive PRANAV JAYESH CHOKSI, as filed for the quarter to Sep 2026. Its latest annual general meeting was on 4 Sep 2026.
Gufic Biosciences board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- Chairperson and managing directorJAYESH PANNALAL CHOKSIRelated to the promoter
- Chief executivePRANAV JAYESH CHOKSI
- Company Secretary and Compliance OfficerAmi N Shah
6 directors3 independent3 executive
- JAYESH PANNALAL CHOKSI · Chairperson and managing directorExecutive · joined Aug 1999 · reappointed Apr 2025 · 1 listed board · 2 committee seats
- PRANAV JAYESH CHOKSI · Chief executiveExecutive · joined Jun 2004 · reappointed Apr 2025 · 1 listed board · 1 committee seat
- PANKAJ JAYAKUMAR GANDHIExecutive · joined Aug 2013 · reappointed Sep 2026 · 1 listed board
- ANU SANJIV AURORAIndependent · joined Dec 2019 · reappointed Dec 2021 · 81 months as independent · 1 listed board · 1 as independent · 2 committee seats, 1 as chair
- KAMAL KISHORE SETHIndependent · joined Jun 2024 · reappointed Jun 2024 · 27 months as independent · 2 listed boards · 2 as independent · 3 committee seats, 3 as chair
- AKSHYA KUMAR MAHAPATRAIndependent · joined Nov 2024 · reappointed Nov 2024 · 22 months as independent · 1 listed board · 1 as independent · 1 committee seat
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
1 director who left
- GOPAL MADHAVDAS DAPTARI, left 24 Nov 2024: Tenure Completion
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 14 Aug 20266 of 6 present3 independent · 13 days in between
- 31 Jul 20266 of 6 present3 independent · 62 days in between
- 29 May 20266 of 6 present3 independent
Audit Committee
Chair KAMAL KISHORE SETH
ANU SANJIV AURORA, JAYESH PANNALAL CHOKSI, AKSHYA KUMAR MAHAPATRA
- 14 Aug 20264 of 4 present3 independent · 13 days in between
- 31 Jul 20264 of 4 present3 independent · 62 days in between
- 29 May 20264 of 4 present3 independent
Nomination and remuneration committee
Chair ANU SANJIV AURORA
KAMAL KISHORE SETH, AKSHYA KUMAR MAHAPATRA
- 31 Jul 20263 of 3 present3 independent · 62 days in between
- 29 May 20263 of 3 present3 independent
Stakeholders Relationship Committee
Chair ANU SANJIV AURORA
JAYESH PANNALAL CHOKSI, PRANAV JAYESH CHOKSI
- 14 Aug 20263 of 3 present1 independent
Risk Management Committee
Chair JAYESH PANNALAL CHOKSI
PRANAV JAYESH CHOKSI, ANU SANJIV AURORA, NAGESH YARRABATHINA, DEVKINANDAN B. ROONGHTA
- 14 Aug 20263 of 3 present1 independent
Corporate Social Responsibility Committee
Chair JAYESH PANNALAL CHOKSI
PRANAV JAYESH CHOKSI, ANU SANJIV AURORA
- 31 Jul 20263 of 3 present1 independent · 62 days in between
- 29 May 20263 of 3 present1 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- M/s. Mittal Agarwal & CompanyPeer-review certificate valid to Apr 2028
1 earlier auditor
- Mittal Agarwal & Company, Chartered AccountantsNamed in the filing for the quarter to Mar 2025
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Gufic Biosciences AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Gufic Biosciences dividend history
Annual general meeting, 4 Sep 2026
30,441 shareholders on the register on 28 Aug 2026; present: 5 promoters and 38 others; votes counted by CS Sandhya R Malhotra / M/s. Manish Ghia & Associates.
To consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended on March 31, 2026 together with Reports of the Board of Directors and Auditors’ thereon and the Audited Consolidated Financial Statements of the Company for the financial year ended on March 31, 2026 including Auditors’ Report thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 79.94% · promoters 100.00% · institutions 87.47% · other public 17.47%
- To declare a Final Dividend @ 10% i.e., Re. 0.10/- per equity share of the face value of Re. 1/- each for the Financial Year ended March 31, 2026.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 79.94% · promoters 100.00% · institutions 87.47% · other public 17.46%
To appoint a director in place of Mr. Pranav J. Choksi (DIN: 00001731), who retires by rotation pursuant to Section 152(6) of the Companies Act, 2013 and being eligible, offers himself for re‐appointment.MoreLess
OrdinaryPromoters have an interest in it100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 79.94% · promoters 100.00% · institutions 87.47% · other public 17.46%
- Ratification of remuneration payable to M/s. Poddar & Co. (FRN: 101734), Cost Auditors for the Financial Year 2026-27.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 79.94% · promoters 100.00% · institutions 87.47% · other public 17.46%
- Re-appointment of Mr. Pankaj J Gandhi (DIN:00001858) as Whole Time Director of the Company and Continuation of Directorship upon attaining the age of 70 years.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.07%
Turnout: all 79.94% · promoters 100.00% · institutions 87.47% · other public 17.46%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 29 Sep 2025, 7 resolutions
31,982 shareholders on the register on 22 Sep 2025; present: 5 promoters and 44 others; votes counted by CS Sandhya R Malhotra / M/s. Manish Ghia & Associates.The company's voting result
To consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended on March 31, 2025 together with Reports of the Board of Directors and Auditors' thereon and the Audited Consolidated Financial Statements of the Company for the financial year ended on March 31, 2025 including Auditors' Report thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 81.72% · promoters 100.00% · institutions 90.21% · other public 23.87%
- To declare a Final Dividend @ 10% i.e., Re. 0.10/- per equity share of the face value of Re. 1/- each for the Financial Year ended March 31, 2025.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 81.72% · promoters 100.00% · institutions 90.21% · other public 23.87%
To appoint a director in place of Mr. Jayesh P. Choksi (DIN: 00001729), who retires by rotation pursuant to Section 152(6) of the Companies Act, 2013 and being eligible, offers himself for re-appointment.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.01% · other public 0.04%
Turnout: all 81.72% · promoters 100.00% · institutions 90.21% · other public 23.86%
- Re-appointment of M/s. Mittal Agarwal and Co., Chartered Accountants (FRN: 131025W) as Statutory Auditors of the Company.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 81.72% · promoters 100.00% · institutions 90.21% · other public 23.86%
- Ratification of Remuneration Payable to M/s. Poddar and Co. (FRN: 101734), Cost Auditors for the Financial Year 2024-25Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 81.72% · promoters 100.00% · institutions 90.21% · other public 23.86%
- Ratification of Remuneration Payable to M/s. Poddar and Co. (FRN: 101734), Cost Auditors for the Financial Year 2025-26Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 81.72% · promoters 100.00% · institutions 90.21% · other public 23.86%
- Appointment of M/s. Manish Ghia and Associates, Practising Company Secretaries as Secretarial Auditor of the CompanyOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 81.72% · promoters 100.00% · institutions 90.21% · other public 23.86%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 6 Feb 2025, 3 resolutions
33,767 shareholders on the register on 3 Jan 2025; votes counted by CS Mannish L Ghia / M/s. Manish Ghia & Associates.The company's voting result
- Appointment of Mr. Akshya Kumar Mahapatra (DIN: 08362446) as an Independent Director of the Company.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 79.78% · promoters 100.00% · institutions 90.06% · other public 17.80%
- Revision in terms of remuneration of Mr. Jayesh P. Choksi, Chairman and Managing Director (DIN: 00001729) of the CompanySpecialPromoters have an interest in it97.58% for2.42% against
Against: promoters 0.00% · institutions 64.98% · other public 0.01%
Turnout: all 79.78% · promoters 100.00% · institutions 90.06% · other public 17.80%
- Revision in terms of remuneration of Mr. Pranav J. Choksi, Whole Time Director (DIN: 00001731) of the CompanySpecialPromoters have an interest in it97.58% for2.42% against
Against: promoters 0.00% · institutions 64.98% · other public 0.07%
Turnout: all 79.78% · promoters 100.00% · institutions 90.06% · other public 17.80%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 25 Sep 2024, 7 resolutions
Present: 5 promoters and 49 others.
To receive, consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended on March 31, 2024 together with Reports ofnthe Board of Directors and Auditors’ thereon and the Audited Consolidated Financial Statements of the Company for the financial year ended on March 31, 2024nincluding Auditors’ Report thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.02%
Turnout: all 79.44% · promoters 100.00% · institutions 92.74% · other public 18.12%
- To declare a Final Dividend @ 10% i.e., Re. 0.10/- per equity share of the face value of Re. 1/- each for the Financial Year ended March 31, 2024.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.03%
Turnout: all 79.44% · promoters 100.00% · institutions 92.74% · other public 18.12%
To appoint a director in place of Mr. Pankaj J. Gandhi (DIN: 00001858), who retires by rotation pursuant to Section 152(6) of the Companies Act, 2013 and being eligible, offers himself for re-appointment.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.02%
Turnout: all 79.44% · promoters 100.00% · institutions 92.74% · other public 18.12%
- Ratification of Remuneration Payable to M/s. Kale & Associates (FRN:001819), Cost Auditors for the Financial Year 2024-25Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.03%
Turnout: all 79.44% · promoters 100.00% · institutions 92.74% · other public 18.12%
- Appointment of Mr. Kamal Kishore Seth (DIN: 00194986) as an Independent Director of the CompanySpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.02% · other public 0.04%
Turnout: all 79.44% · promoters 100.00% · institutions 92.74% · other public 18.12%
- Re-appointment of Mr. Jayesh P. Choksi (DIN: 00001729) as Chairman & Mananging Director of the Company.SpecialPromoters have an interest in it99.99% for0.01% against
Against: promoters 0.00% · institutions 0.27% · other public 0.04%
Turnout: all 79.44% · promoters 100.00% · institutions 92.74% · other public 18.12%
- Re-appointment of Mr. Pranav J. Choksin(DIN: 00001731) as Whole Time Director of the Company.SpecialPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.06%
Turnout: all 79.44% · promoters 100.00% · institutions 92.74% · other public 18.12%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 29 Sep 2023, 10 resolutions
Present: 5 promoters and 59 others.
To receive, consider and adopt the Audited Financial Statements of the Company for the Financial Year ended March 31, 2023, including the Audited Balance Sheet as at March 31, 2023, the Statement of Profit & Loss and the Cash Flow Statement for the year ended on that date together with the Reports of Board of Directors and Auditors thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 79.96% · promoters 100.00% · institutions 94.56% · other public 12.04%
- To declare a Final Dividend @ 10 % i.e., Re. 0.10/- per equity share of the face value of Re. 1/- each for the Financial Year ended March 31, 2023.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.04%
Turnout: all 79.96% · promoters 100.00% · institutions 94.56% · other public 12.04%
To appoint a director in place of Mr. Pranav J. Choksi (DIN: 00001731), who retires by rotation pursuant to Section 152(6) of the Companies Act, 2013 and being eligible, offers himself for re-appointment.MoreLess
Ordinary99.94% for0.06% againstAgainst: promoters 0.00% · institutions 2.19% · other public 0.01%
Turnout: all 79.96% · promoters 100.00% · institutions 94.56% · other public 12.04%
To appoint a director in place of Mr. Bal Ram H. Singh (DIN: 06918085), who retires by rotation pursuant to Section 152(6) of the Companies Act, 2013 and being eligible, offers himself for re-appointment.MoreLess
Ordinary98.65% for1.35% againstAgainst: promoters 0.00% · institutions 48.43% · other public 0.01%
Turnout: all 79.96% · promoters 100.00% · institutions 94.56% · other public 12.04%
- Ratification of Remuneration Payable to M/s. Kale & Associates (FRN:001819), Cost Auditors for the Financial Year 2023-24Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 79.95% · promoters 100.00% · institutions 94.56% · other public 12.01%
- Continuation of Directorship of Mr. Jayesh P. Choksi (DIN: 00001729) as Chairman and Managing Director on attaining the age of 70 years.SpecialPromoters have an interest in it99.94% for0.06% against
Against: promoters 0.00% · institutions 2.19% · other public 0.04%
Turnout: all 79.96% · promoters 100.00% · institutions 94.56% · other public 12.04%
- Continuation of Directorship of Mr. Gopal M. Daptari (DIN: 07660662) as a Non-Executive Independent Director on attaining the age of 75 years.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.04%
Turnout: all 79.96% · promoters 100.00% · institutions 94.56% · other public 12.04%
- Approval of Gufic Biosciences Limited Employee Stock Option Plan, 2023 (Gufic ESOP 2023) and grant of Employee Stock Options to the employees of the Company thereafter.Special99.37% for0.63% against
Against: promoters 0.00% · institutions 22.47% · other public 0.05%
Turnout: all 79.96% · promoters 100.00% · institutions 94.56% · other public 12.04%
- Extension of the Gufic Biosciences Limited Employee Stock Option Plan 2023 (Gufic ESOP 2023) to the eligible employees of the subsidiary(ies) and/or associate company(ies), if any of the Company.Special99.37% for0.63% against
Against: promoters 0.00% · institutions 22.47% · other public 0.05%
Turnout: all 79.96% · promoters 100.00% · institutions 94.56% · other public 12.04%
- To consider and approve the issue of 33,33,000 equity shares on a Preferential basis to the Non-Promoter of the Company.Special99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.35%
Turnout: all 79.96% · promoters 100.00% · institutions 94.56% · other public 12.04%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 2 Sep 2022, 9 resolutions
Present: 5 promoters and 71 others.
To receive, consider and adopt the Audited Financial Statements of the Company for the Financial Year ended March 31, 2022, including the Audited Balance Sheet as at March 31, 2022, the Statement of Profit & Loss and the Cash Flow Statement for the year ended on that date together with the Reports of Board of Directors and Auditors thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 74.29% · promoters 93.18% · institutions 89.80% · other public 13.18%
- To declare a Final Dividend @ 10 % i.e.,Re. 0.10/- per equity share of the face value of Re. 1/- each for the Financial Year ended March 31, 2022.Ordinary99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.14%
Turnout: all 74.29% · promoters 93.18% · institutions 89.80% · other public 13.18%
To appoint a director in place of Mr. Jayesh P. Choksi (DIN: 00001729), who retires by rotation in terms of Section 152(6) of the Companies Act, 2013 and being eligible, offers himself for re-appointment.MoreLess
Ordinary99.96% for0.04% againstAgainst: promoters 0.00% · institutions 2.46% · other public 0.00%
Turnout: all 74.29% · promoters 93.18% · institutions 89.80% · other public 13.18%
- To appoint a director in place of Mr. Dilip Ghosh (DIN: 00412406), who retires by rotation in terms of Section 152(6) of the Companies Act, 2013 and being eligible, offers himself for re-appointment.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 74.29% · promoters 93.18% · institutions 89.80% · other public 13.18%
- Re-appointment of Dr. Rabi N. Sahoo (DIN: 01237464) as an Independent Director of the Company.Special98.57% for1.43% against
Against: promoters 0.00% · institutions 81.61% · other public 0.00%
Turnout: all 74.29% · promoters 93.18% · institutions 89.80% · other public 13.18%
- Continuation of Directorship of Mr. Dilip B. Ghosh (DIN: 00412406) as a Whole Time Director upon attaining the age of 70 years.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 74.29% · promoters 93.18% · institutions 89.80% · other public 13.17%
- Ratification of remuneration payable to M/s. Kale & Associates (FRN: 001819), Cost Auditors, for the Financial Year 2022-23.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 74.29% · promoters 93.18% · institutions 89.80% · other public 13.18%
- Increase in the Borrowing Limits of the Company under Section 180(1)(c) of the Companies Act, 2013.Special99.63% for0.37% against
Against: promoters 0.00% · institutions 20.83% · other public 0.02%
Turnout: all 74.29% · promoters 93.18% · institutions 89.80% · other public 13.18%
- Creation of charges on the properties of the Company in respect of borrowings under Section 180(1)(a) of the Companies Act, 2013Special99.63% for0.37% against
Against: promoters 0.00% · institutions 20.83% · other public 0.10%
Turnout: all 74.29% · promoters 93.18% · institutions 89.80% · other public 13.18%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 19 Jan 2022, 1 resolution
- Re-appointment of Mr. Pankaj J. Gandhi (DIN: 00001858) as Whole Time DirectorOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.05%
Turnout: all 70.53% · promoters 86.15% · institutions 93.86% · other public 12.50%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 20 Sep 2021, 7 resolutions
Present: 3 promoters and 84 others.
To receive, consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2021, including the Audited Balance Sheet as at March 31, 2021, the Statement of Profit & Loss and the Cash Flow Statement for the year ended on that date together with the Report of Board of Directors and Auditors thereon. n nMoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.02%
Turnout: all 43.00% · promoters 50.96% · institutions 98.77% · other public 4.61%
- To declare a Final Dividend @ 10 % i.e., Re. 0.10/- per equity share of the face value of Re. 1/- each for the financial year ended March 31, 2021. n nOrdinary99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.23%
Turnout: all 43.00% · promoters 50.96% · institutions 98.77% · other public 4.61%
To appoint a director in place of Mr. Pranav J. Choksi (DIN 00001731), who retires by rotation in terms of section 152(6) of the Companies Act, 2013 and being eligible, offers himself for re-appointment. n nMoreLess
Ordinary99.97% for0.03% againstAgainst: promoters 0.00% · institutions 0.25% · other public 0.21%
Turnout: all 43.00% · promoters 50.96% · institutions 98.77% · other public 4.61%
To appoint a director in place of Mr. Pankaj J. Gandhi (DIN 00001858), who retires by rotation in terms of section 152(6) of the Companies Act, 2013 and being eligible, offers himself for re-appointment. n nMoreLess
Ordinary99.98% for0.02% againstAgainst: promoters 0.00% · institutions 0.00% · other public 0.85%
Turnout: all 43.00% · promoters 50.96% · institutions 98.77% · other public 4.61%
- Re-appointment of Dr. Anu S. Aurora (DIN : 05120192) as an Independent Director. n nSpecial99.96% for0.04% against
Against: promoters 0.00% · institutions 0.25% · other public 0.86%
Turnout: all 43.00% · promoters 50.96% · institutions 98.77% · other public 4.61%
- Appointment of Mr. Dilip Ghosh (DIN: 00412406) as a Whole Time Director. n nOrdinary99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.66%
Turnout: all 43.00% · promoters 50.96% · institutions 98.77% · other public 4.61%
- Retification of remuneration payable to M/s Kale & Associates, Cost Auditors, for the Finacial year 2021-22Ordinary99.99% for0.01% against
Against: promoters 0.00% · institutions 0.00% · other public 0.66%
Turnout: all 43.00% · promoters 50.96% · institutions 98.77% · other public 4.61%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
How mutual funds voted
Fund houses must disclose how they vote at every meeting of a company they hold.Funds that hold it
Mutual fund votes, meeting of 4 Sep 2026, 5 fund houses
To consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended on March 31, 2026 together with Reports of the Board of Directors and Auditors’ thereon and the Audited Consolidated Financial Statements of the Company for the financial year ended on March 31, 2026 including Auditors’ Report thereon.MoreLess
5 for0 against- To declare a Final Dividend @ 10% i.e., Re. 0.10/- per equity share of the face value of Re. 1/- each for the Financial Year ended March 31, 2026.5 for0 against
To appoint a director in place of Mr. Pranav J. Choksi (DIN: 00001731), who retires by rotation pursuant to Section 152(6) of the Companies Act, 2013 and being eligible, offers himself for re‐appointment.MoreLess
5 for0 against- Ratification of remuneration payable to M/s. Poddar & Co. (FRN: 101734), Cost Auditors for the Financial Year 2026-27.5 for0 against
- Re-appointment of Mr. Pankaj J Gandhi (DIN:00001858) as Whole Time Director of the Company and Continuation of Directorship upon attaining the age of 70 years.5 for0 against
Mutual fund votes, meeting of 29 Sep 2025, 5 fund houses
Each resolution counts the houses whose vote was matched to it; the rest are listed last.
To consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended on March 31, 2025 together with Reports of the Board of Directors and Auditors' thereon and the Audited Consolidated Financial Statements of the Company for the financial year ended on March 31, 2025 including Auditors' Report thereon.MoreLess
5 for0 against- To declare a Final Dividend @ 10% i.e., Re. 0.10/- per equity share of the face value of Re. 1/- each for the Financial Year ended March 31, 2025.5 for0 against
To appoint a director in place of Mr. Jayesh P. Choksi (DIN: 00001729), who retires by rotation pursuant to Section 152(6) of the Companies Act, 2013 and being eligible, offers himself for re-appointment.MoreLess
Against Bandhan Mutual Fund
- Bandhan Mutual FundCompliant with law. No concern on the merits of appointee. Governance concern: Holds combined position of Chairman and Managing Director of the company.
4 for1 against- Re-appointment of M/s. Mittal Agarwal and Co., Chartered Accountants (FRN: 131025W) as Statutory Auditors of the Company.5 for0 against
- Appointment of M/s. Manish Ghia and Associates, Practising Company Secretaries as Secretarial Auditor of the Company5 for0 against
4 proposals not matched to one resolution
- 5) Ratify remuneration of Rs. 300,000 payable to Poddar & Co. as cost auditors for FY25.1 for0 against
- 6) Ratify remuneration of Rs. 300,000 payable to Poddar & Co. as cost auditors for FY26.1 for0 against
Ratification of remuneration of Rs. 3,00,000/- per annum plus applicable taxes and reimbursement of actual travel and out of pocket expenses incurred in connection with the audit, as approved by the Board of Directors of the Company on the recommendation of the Audit Committee, payable to M/s. Poddar and Co. (FRN: 101734), Cost Accountants, Mumbai, who was appointed as Cost Auditors of the Company by the Board of Directors for conducting audit of the cost records of the Company for the Financial Year ending March 31, 2026.MoreLess
4 for0 againstRatification of remuneration of Rs. 3,00,000/- per annum plus applicable taxes and reimbursement of actual travel and out of pocket expenses incurred in connection with the audit, as approved by the Board of Directors of the Company on the recommendation of the Audit Committee, payable to M/s. Poddar and Co. (FRN: 101734), Cost Accountants, Mumbai, who was appointed as Cost Auditors of the Company by the Board of Directors for conducting audit of the cost records of the Company for the Financial Year ending March 31, 2025.MoreLess
4 for0 against
Mutual fund votes, meeting of 6 Feb 2025, 6 fund houses
3 proposals
- Appointment of Mr. Akshya Kumar Mahapatra (DIN: 08362446) as an Independent Director of the Company.6 for0 against
- Revision in terms of remuneration of Mr. Jayesh P. Choksi, Chairman and Managing Director (DIN: 00001729) of the Company
Against Bandhan Mutual Fund, Bank of India Mutual Fund, ICICI Prudential Mutual Fund, Motilal Oswal Mutual Fund
- Bandhan Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Governance concern: Holds combined position of Chairman and Managing Director of the company. Significant increase in the proposed remuneration leading to excessive remuneration. No absolute cap on variable pay or total remuneration.
- Bank of India Mutual FundJayesh Choksi, 70, is the Promoter, Chairperson and Managing Director of the company. At the 2024 AGM, he was reappointed for another term of five years with effect from 1 April 2025. He received Rs. 4.8 mn in FY24. Based on his terms approved at 2024 AGM, we estimate his FY25 remuneration at Rs. 5.4 mn. As per the revised terms stated in the notice, he will be entitled to a salary of upto Rs. 50.0 mn per annum. Historically, his remuneration has been lower than peers. Therefore, we understand the rationale for an increase in his fixed pay. However, his revised remuneration terms also include a commission component with payout upto 5% of net profits. We believe the threshold of 5% is significantly high. In the absence of guidance or cap, we are unable to estimate his overall remuneration including commission payout for FY26 and onwards. We expect companies to disclose performance metrics that determine variable pay and to cap the remuneration (including commission) in absolute terms. Therefore, we do not support the resolution.
- ICICI Prudential Mutual FundThe AMC has voted against the resolution as the proposed threshold of remuneration is significantly high
2 for4 against - Revision in terms of remuneration of Mr. Pranav J. Choksi, Whole Time Director (DIN: 00001731) of the Company
Against Bandhan Mutual Fund, Bank of India Mutual Fund, ICICI Prudential Mutual Fund, Motilal Oswal Mutual Fund
- Bandhan Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Governance concern: Significant increase in the proposed remuneration leading to excessive remuneration. No absolute cap on variable pay or total remuneration.
- Bank of India Mutual FundPranav Choksi, 41, is a part of the promoter group. He was first appointed to the board on 25 June 2004. He is an Executive Director designated as the CEO He received Rs. 4.4 mn in FY24. Based on his terms approved at 2024 AGM, we estimate his FY25 remuneration at Rs. 4.9 mn. As per the revised terms stated in the notice, he will be entitled to a salary of upto Rs. 50.0 mn per annum. Historically, his remuneration has been lower than peers. Therefore, we understand the rationale for an increase in his fixed pay. However, his revised remuneration terms also include a commission component with payout upto 5% of net profits. We believe the threshold of 5% is significantly high. In the absence of guidance or cap, we are unable to estimate his overall remuneration including commission payout for FY26 and onwards. We expect companies to disclose performance metrics that determine variable pay and to cap the remuneration (including commission) in absolute terms. Therefore, we do not support the resolution.
- ICICI Prudential Mutual FundThe AMC has voted against the resolution as the proposed threshold of remuneration is significantly high
2 for4 against
Mutual fund votes, meeting of 25 Sep 2024, 6 fund houses
7 proposals
To receive, consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended on March 31, 2024 together with Reports ofnthe Board of Directors and Auditors’ thereon and the Audited Consolidated Financial Statements of the Company for the financial year ended on March 31, 2024nincluding Auditors’ Report thereon.MoreLess
6 for0 against- To declare a Final Dividend @ 10% i.e., Re. 0.10/- per equity share of the face value of Re. 1/- each for the Financial Year ended March 31, 2024.6 for0 against
To appoint a director in place of Mr. Pankaj J. Gandhi (DIN: 00001858), who retires by rotation pursuant to Section 152(6) of the Companies Act, 2013 and being eligible, offers himself for re-appointment.MoreLess
6 for0 against- Ratification of Remuneration Payable to M/s. Kale & Associates (FRN:001819), Cost Auditors for the Financial Year 2024-256 for0 against
- Appointment of Mr. Kamal Kishore Seth (DIN: 00194986) as an Independent Director of the Company
Against Bandhan Mutual Fund, Groww Mutual Fund
- Bandhan Mutual Fund, Groww Mutual FundNo concern on the merit of proposed appointee. Non-Compliance with Regulation 17(1A) of SEBI LODR, 2015: No prior approval for appointment of director above 75 years of age.
4 for2 against - Re-appointment of Mr. Jayesh P. Choksi (DIN: 00001729) as Chairman & Mananging Director of the Company.
Against Bandhan Mutual Fund, Groww Mutual Fund
- Bandhan Mutual Fund, Groww Mutual FundCompliant with law. No concern on the merits of appointee. Governance concern: Holds combined position of Chairman and Managing Director of the company
4 for2 against - Re-appointment of Mr. Pranav J. Choksin(DIN: 00001731) as Whole Time Director of the Company.6 for0 against
Mutual fund votes, meeting of 29 Sep 2023, 2 fund houses
11 proposals
Each resolution counts the houses whose vote was matched to it; the rest are listed last.
To receive, consider and adopt the Audited Financial Statements of the Company for the Financial Year ended March 31, 2023, including the Audited Balance Sheet as at March 31, 2023, the Statement of Profit & Loss and the Cash Flow Statement for the year ended on that date together with the Reports of Board of Directors and Auditors thereon.MoreLess
2 for0 against- To declare a Final Dividend @ 10 % i.e., Re. 0.10/- per equity share of the face value of Re. 1/- each for the Financial Year ended March 31, 2023.2 for0 against
To appoint a director in place of Mr. Pranav J. Choksi (DIN: 00001731), who retires by rotation pursuant to Section 152(6) of the Companies Act, 2013 and being eligible, offers himself for re-appointment.MoreLess
2 for0 againstTo appoint a director in place of Mr. Bal Ram H. Singh (DIN: 06918085), who retires by rotation pursuant to Section 152(6) of the Companies Act, 2013 and being eligible, offers himself for re-appointment.MoreLess
Against SBI Mutual Fund
- SBI Mutual FundDr. Bal Ram H Singh, 65, is Founder of Prime Bio and Institute of Advanced Sciences. He has been on the board of this company since 29 May 2018. He attended only one meeting out of seven (14%) held in FY23, and four out of twenty-three board meetings (17%) held since FY21. We expect directors to attend all board meetings, or at the very least, 75% of the board meetings held over a three-year period. We do not support his reappointment.
1 for1 against- Ratification of Remuneration Payable to M/s. Kale & Associates (FRN:001819), Cost Auditors for the Financial Year 2023-242 for0 against
- Continuation of Directorship of Mr. Jayesh P. Choksi (DIN: 00001729) as Chairman and Managing Director on attaining the age of 70 years.2 for0 against
- Continuation of Directorship of Mr. Gopal M. Daptari (DIN: 07660662) as a Non-Executive Independent Director on attaining the age of 75 years.2 for0 against
- Approval of Gufic Biosciences Limited Employee Stock Option Plan, 2023 (Gufic ESOP 2023) and grant of Employee Stock Options to the employees of the Company thereafter.2 for0 against
- Extension of the Gufic Biosciences Limited Employee Stock Option Plan 2023 (Gufic ESOP 2023) to the eligible employees of the subsidiary(ies) and/or associate company(ies), if any of the Company.1 for0 against
- To consider and approve the issue of 33,33,000 equity shares on a Preferential basis to the Non-Promoter of the Company.2 for0 against
1 proposal not matched to one resolution
- 9) Approve grant of Gufic Biosciences Ltd Employee Stock Option Plan 2023 to employees of subsidiaries and/or associates of the company.1 for0 against
Mutual fund votes, meeting of 2 Sep 2022, 2 fund houses
9 proposals
To receive, consider and adopt the Audited Financial Statements of the Company for the Financial Year ended March 31, 2022, including the Audited Balance Sheet as at March 31, 2022, the Statement of Profit & Loss and the Cash Flow Statement for the year ended on that date together with the Reports of Board of Directors and Auditors thereon.MoreLess
2 for0 against- To declare a Final Dividend @ 10 % i.e.,Re. 0.10/- per equity share of the face value of Re. 1/- each for the Financial Year ended March 31, 2022.2 for0 against
To appoint a director in place of Mr. Jayesh P. Choksi (DIN: 00001729), who retires by rotation in terms of Section 152(6) of the Companies Act, 2013 and being eligible, offers himself for re-appointment.MoreLess
2 for0 against- To appoint a director in place of Mr. Dilip Ghosh (DIN: 00412406), who retires by rotation in terms of Section 152(6) of the Companies Act, 2013 and being eligible, offers himself for re-appointment.2 for0 against
- Re-appointment of Dr. Rabi N. Sahoo (DIN: 01237464) as an Independent Director of the Company.
Against SBI Mutual Fund
- SBI Mutual FundRabi Sahoo, 62, graduated in pharmacology from AIIMS and is a healthcare professional with 33 years of experience in regulatory affairs, clinical research & medical services. Rabi Sahoo had attended 72% meetings in FY22, and 44% in FY21 which is below our threshold of 75% attendance in the last three years. Given the low attendance levels over his first term, we are unable to support his reappointment as independent director for a second term of two years While the company has provided clarification citing reasons for the low attendance of the Independent Director, the statutory meeting attendance is also below requisite threshold and hence we vote against the resolution.
1 for1 against - Continuation of Directorship of Mr. Dilip B. Ghosh (DIN: 00412406) as a Whole Time Director upon attaining the age of 70 years.2 for0 against
- Ratification of remuneration payable to M/s. Kale & Associates (FRN: 001819), Cost Auditors, for the Financial Year 2022-23.2 for0 against
- Increase in the Borrowing Limits of the Company under Section 180(1)(c) of the Companies Act, 2013.2 for0 against
- Creation of charges on the properties of the Company in respect of borrowings under Section 180(1)(a) of the Companies Act, 20132 for0 against
Mutual fund votes, meeting of 19 Jan 2022, 1 fund house
1 proposal
- Re-appointment of Mr. Pankaj J. Gandhi (DIN: 00001858) as Whole Time Director1 for0 against
Mutual fund votes, meeting of 20 Sep 2021, 2 fund houses
7 proposals
To receive, consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2021, including the Audited Balance Sheet as at March 31, 2021, the Statement of Profit & Loss and the Cash Flow Statement for the year ended on that date together with the Report of Board of Directors and Auditors thereon. n nMoreLess
2 for0 against- To declare a Final Dividend @ 10 % i.e., Re. 0.10/- per equity share of the face value of Re. 1/- each for the financial year ended March 31, 2021. n n2 for0 against
To appoint a director in place of Mr. Pranav J. Choksi (DIN 00001731), who retires by rotation in terms of section 152(6) of the Companies Act, 2013 and being eligible, offers himself for re-appointment. n nMoreLess
2 for0 againstTo appoint a director in place of Mr. Pankaj J. Gandhi (DIN 00001858), who retires by rotation in terms of section 152(6) of the Companies Act, 2013 and being eligible, offers himself for re-appointment. n nMoreLess
2 for0 against- Re-appointment of Dr. Anu S. Aurora (DIN : 05120192) as an Independent Director. n n2 for0 against
- Appointment of Mr. Dilip Ghosh (DIN: 00412406) as a Whole Time Director. n n2 for0 against
- Retification of remuneration payable to M/s Kale & Associates, Cost Auditors, for the Finacial year 2021-222 for0 against
Each fund house counted once, from its own disclosure; the reasons are its own words.
Fines and tax disputes
Reported in the filing for the quarter to Sep 2026.
- Fine or penaltyJoint Director In Charge, Employees State Insurance Corporation SRO MarolSince 28 Jul 2026
The Joint Director in Charge, SRO Marol, has issued a show cause notice dated 28.07.2026, proposing the levy of damages amounting to ₹6,97,337/- (Rupees Six Lakh Ninety-Seven Thousand Three Hundred and Thirty-Seven Only) for delayed payment of wage contributions for the periods from April 2013 to March 2015 and April 2020 to October 2020. The Company has submitted its response to the show-cause notice, seeking its withdrawal and requesting that no penal damages be imposed.
Delayed payment of wage contribution for the periods April 2013 to March 2015 and April 2020 to October 2020 - Tax disputeAssessing Officer - Income Tax DepartmentSince 14 Apr 2025The matter has been heard by the Hon'ble ITAT and the order is awaited.
At the filing before: The Company had filed an appeal before the Hon'ble Commissioner of Income Tax (Appeals), National Faceless Appeal Centre, Delhi, against the Assessment Order passed under Section 143(3) read with Section 144B of the Income Tax Act, 1961 for Assessment Year 2023-24, challenging the disallowance of certain deductions claimed by the Company. Pursuant to the appellate order, the tax demand was reduced to Rs. 11,76,198/-. The Income Tax Department filed an appeal before the Hon'ble Income Tax Appellate Tribunal (ITAT) against the relief granted to the Company, and the Company filed a cross-objection. The matter is pending for hearing.MoreLess
- Tax disputeIncome Tax DepartmentSince 21 Jan 2026The Appeal filed by the Company has been allowed in favour of the Company.
At the filing before: The Company received a Tax Demand of Rs. 4,33,36,680/- under Section 143(1) of the Income Tax Act, 1961 ("Act") on account of disallowance of expenditure under Section 35(1)(i) and (iv) read with Clause 20 of Tax Audit Report for the Assessment Year 2024-25. The Company filed an appeal before the Commissioner of Income Tax (Appeals) within the prescribed timeline under the Act, which was pending adjudication.MoreLess
In the company's own words, from its latest governance filing.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- Yes
- The chair is related to the managing director
- Yes
- The filing has a part on fines and penalties
- Yes
- The filing has a part on tax disputes
- Yes
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.